Cytokine gene regulation by NFAT

Point mutations in the transcription factor NFAT define sets of cytokine genes whose regulation is dependent on or independent of cooperation between NFAT and Fos/Jun

Written byJonathan Weitzman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Cooperation between nuclear factor of activated T cells (NFAT) and the Fos/Jun transcription factors is central to integrating converging signals upon lymphocyte activation. In the 1 September EMBO Journal Macian et al, engineered mutants of NFAT1 that no longer interact with Fos/Jun dimers, but still bind DNA and activate transcription. These proved to be powerful tools for defining the need for NFAT–Fos–Jun cooperation in regulating cytokine gene expression. The target genes for NFAT can be divided into those that absolutely require cooperation for activation (for example, the genes for interleukin (IL)-2, GM-CSF, IL-3, IL-4 and FasL), and those that are induced by NFAT alone (for example, TNFalpha and IL-13). Cooperation is also functionally important for activation-induced cell death of lymphocytes. These results have therapeutic implications for the development of more specific immunosuppressive drugs.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform